Table 2 Baseline characteristics of participants in the Phys-Can Study
| Â | Randomised to 6Â months of | |
|---|---|---|
Low-moderate intensity training (n = 289) | High intensity training (n = 288) | |
Age (years) mean (SD) | 59 (12) | 59 (12) |
Sex n (%) | Â | Â |
 Male | 55 (19) | 57 (20) |
 Female | 234 (81) | 231 (80) |
Education n (%) | Â | Â |
 Primary | 32 (11) | 30 (11) |
 Secondary | 59 (21) | 77 (28) |
 Tertiary | 173 (62) | 163 (58) |
 Other | 15 (5) | 9 (3) |
Diagnosis n (%) | Â | Â |
 Breast cancer | 229 (79) | 228 (79) |
 Colorectal cancer | 12 (4) | 11 (4) |
 Prostate cancer | 48 (17) | 49 (17) |
Weight status n (%) | Â | Â |
 Underweight/normal weight (BMI < 25 kg/m2) | 135 (50) | 132 (49) |
 Pre-obese (BMI ≥ 25 kg/m2 < 30 kg/m2) | 98 (36) | 90 (33) |
Obese (BMI ≥ 30 kg/m2) | 39 (14) | 48 (18) |
Treated with chemotherapy n (%) | 157 (55) | 151 (52) |
Comorbidities n (%) | Â | Â |
 None | 109 (39) | 113 (42) |
 One or more | 170 (61) | 157 (58) |
Exercise stage of change* median (IQR) | Â | Â |
 Cardiovascular training | 3 (3–5) | 3 (3–5) |
 Strength training | 3 (2–3) | 3 (2–4) |
VO2 max (mL/kg/min) mean (SD) | 30.1 (7.1) | 30.7 (7.1) |
MVPA (h/day) mean (SD) | 1.2 (0.8) | 1.2 (0.9) |